The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Klingenstein Paul H since year 2005.
The trader's CIK number is 935463.
At the time of this reporting, Klingenstein Paul H is the Director of Conatus Pharmaceuticals Inc .
(stock ticker symbol CNAT).
See this page for all insider trading activities at Conatus Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2013-07-30||CNAT||Conatus Pharmaceuticals Inc||Buy||107,422||11.00||1,181,642|
|2013-07-30||CNAT||Conatus Pharmaceuticals Inc||Sale||566||11.00||6,226|
|2011-11-21||CLVS||Clovis Oncology, Inc.||Buy||399,291||13.00||5,190,783|
|2010-11-30||ANAC||Anacor Pharmaceuticals Inc||Buy||300,000||5.00||1,500,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Klingenstein Paul H (Director of Conatus Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.